SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

GB Sciences Inc. – ‘10-Q’ for 12/31/20 – ‘R35’

On:  Tuesday, 2/16/21, at 2:16pm ET   ·   For:  12/31/20   ·   Accession #:  1437749-21-2961   ·   File #:  0-55462

Previous ‘10-Q’:  ‘10-Q’ on 11/13/20 for 9/30/20   ·   Next:  ‘10-Q’ on 8/13/21 for 6/30/21   ·   Latest:  ‘10-Q’ on 2/12/24 for 12/31/23   ·   6 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/21  GB Sciences Inc.                  10-Q       12/31/20   54:8.3M                                   RDG Filings/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    761K 
 2: EX-10.1     Exhibit 10.1 Judgment Settlement Agreement          HTML     49K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     19K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     19K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     17K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     17K 
13: R1          Document And Entity Information                     HTML     45K 
14: R2          Condensed Consolidated Balance Sheets (Current      HTML    107K 
                Period Unaudited)                                                
15: R3          Condensed Consolidated Balance Sheets (Current      HTML     30K 
                Period Unaudited) (Parentheticals)                               
16: R4          Condensed Consolidated Statements of Operations     HTML    155K 
                (Unaudited)                                                      
17: R5          Condensed Consolidated Statements of Cash Flows     HTML    178K 
                (Unaudited)                                                      
18: R6          Condensed Consolidated Statements of Changes in     HTML    112K 
                Stockholders' Equity/(Deficit) (Unaudited)                       
19: R7          Note 1 - Background and Significant Accounting      HTML     83K 
                Policies                                                         
20: R8          Note 2 - Going Concern                              HTML     24K 
21: R9          Note 3 - Discontinued Operations                    HTML    396K 
22: R10         Note 4 - Leases (Continuing Operations)             HTML     21K 
23: R11         Note 5 - Notes Payable and Line of Credit           HTML     62K 
24: R12         Note 6 - Convertible Notes                          HTML     56K 
25: R13         Note 7 - Capital Transactions                       HTML     29K 
26: R14         Note 8 - Commitments and Contingencies              HTML     27K 
27: R15         Note 9 - Related Party Transactions                 HTML     22K 
28: R16         Note 10 - Sale of Membership Interests in GB        HTML     28K 
                Sciences Louisiana, LLC                                          
29: R17         Note 11 - Sale of Membership Interests in Nevada    HTML     33K 
                Subsidiaries                                                     
30: R18         Note 12 - Subsequent Events                         HTML     21K 
31: R19         Significant Accounting Policies (Policies)          HTML    124K 
32: R20         Note 1 - Background and Significant Accounting      HTML     54K 
                Policies (Tables)                                                
33: R21         Note 3 - Discontinued Operations (Tables)           HTML    391K 
34: R22         Note 5 - Notes Payable and Line of Credit (Tables)  HTML     43K 
35: R23         Note 1 - Background and Significant Accounting      HTML     20K 
                Policies (Details Textual)                                       
36: R24         Note 1 - Background and Significant Accounting      HTML     59K 
                Policies - Earnings (Loss) Per Share (Details)                   
37: R25         Note 2 - Going Concern (Details Textual)            HTML     27K 
38: R26         Note 3 - Discontinued Operations (Details Textual)  HTML     46K 
39: R27         Note 3 - Discontinued Operations - Discontinued     HTML    256K 
                Operations (Details)                                             
40: R28         Note 3 - Discontinued Operations - Schedule of      HTML     29K 
                Inventory (Details)                                              
41: R29         Note 3 - Discontinued Operations - Future Minimum   HTML     40K 
                Lease Payments (Details)                                         
42: R30         Note 4 - Leases (Continuing Operations) (Details    HTML     27K 
                Textual)                                                         
43: R31         Note 5 - Notes Payable and Line of Credit (Details  HTML    155K 
                Textual)                                                         
44: R32         Note 5 - Notes Payable and Line of Credit -         HTML     70K 
                Schedule of Debt Payable (Details)                               
45: R33         Note 6 - Convertible Notes (Details Textual)        HTML    295K 
46: R34         Note 7 - Capital Transactions (Details Textual)     HTML    109K 
47: R35         Note 8 - Commitments and Contingencies (Details     HTML     46K 
                Textual)                                                         
48: R36         Note 9 - Related Party Transactions (Details        HTML     31K 
                Textual)                                                         
49: R37         Note 10 - Sale of Membership Interests in GB        HTML     65K 
                Sciences Louisiana, LLC (Details Textual)                        
50: R38         Note 11 - Sale of Membership Interests in Nevada    HTML     98K 
                Subsidiaries (Details Textual)                                   
51: R39         Note 12 - Subsequent Events (Details Textual)       HTML     35K 
53: XML         IDEA XML File -- Filing Summary                      XML     93K 
52: EXCEL       IDEA Workbook of Financial Reports                  XLSX     76K 
 7: EX-101.INS  XBRL Instance -- gblx-20201231                       XML   2.59M 
 9: EX-101.CAL  XBRL Calculations -- gblx-20201231_cal               XML    196K 
10: EX-101.DEF  XBRL Definitions -- gblx-20201231_def                XML   1.39M 
11: EX-101.LAB  XBRL Labels -- gblx-20201231_lab                     XML   1.14M 
12: EX-101.PRE  XBRL Presentations -- gblx-20201231_pre              XML   1.39M 
 8: EX-101.SCH  XBRL Schema -- gblx-20201231                         XSD    184K 
54: ZIP         XBRL Zipped Folder -- 0001437749-21-002961-xbrl      Zip    193K 


‘R35’   —   Note 8 – Commitments and Contingencies (Details Textual)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.20.4
Note 8 - Commitments and Contingencies (Details Textual)
9 Months Ended 39 Months Ended
USD ($)
USD ($)
USD ($)
USD ($)
USD ($)
USD ($)
USD ($)
USD ($)
Repayment of Iliad Note [Member] | Judicial Ruling [Member]                
Litigation Settlement, Amount Awarded to Other Party       $ 3,264,594        
Litigation Settlement, Payment $ 3,006,014              
Payment of Services Provided by Contractor [Member] | Pending Litigation [Member]                
Loss Contingency, Damages Sought, Value         $ 73,050      
Payment of Services Provided by Contractor [Member] | Settled Litigation [Member]                
Payments for Legal Settlements   $ 25,000            
Reduction in Cost Basis of Fixed Asset Related to Litigation   $ 48,050            
Agreement With Louisiana State University AgCenter [Member]                
Term of Agreement (Year)           5 years 3 years  
Option to Renew Agreement, Amount           2    
Term of Agreement, Renewal (Year)           5 years    
Research and Development Expense, Total           $ 500,000 $ 250,000 $ 750,000
Annual Research Contributions     $ 250,000          

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:2/16/21
For Period end:12/31/20
12/16/208-K
9/17/20
8/24/20
7/14/20
4/22/20
9/18/17
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/21/21  GB Sciences Inc.                  424B3                  1:3.5M                                   RDG Filings/FA
 9/17/21  GB Sciences Inc.                  S-1                  104:17M                                    RDG Filings/FA
 7/06/21  GB Sciences Inc.                  10-K        3/31/21   92:11M                                    RDG Filings/FA


3 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/28/20  GB Sciences Inc.                  10-K        3/31/20   96:12M                                    RDG Filings/FA
 6/27/14  GB Sciences Inc.                  10-K        3/31/14   11:1.2M                                   Henrie Gary R/FA
 2/12/02  GB Sciences Inc.                  SB-2                   1:166K                                   Elec Delivery Sy… Inc/FA
Top
Filing Submission 0001437749-21-002961   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 7:35:33.1am ET